Novartis (NVS) and Roche executives are due to meet with Swiss government officials this week as President Donald Trump urges pharmaceutical firms to lower their prices in the US, Reuters reported Monday, citing two sources.
Economy Minister Guy Parmelin and Health Minister Elizabeth Baume-Schneider will meet with executives of the two drug makers as well as other companies, the sources told the news outlet.
Switzerland is aiming to negotiate with the US to lower the 39% tariffs announced on its exports, according to the report.
The discussions may also be about encouraging the drug makers to invest more in the US and reduce Switzerland's trade surplus with the country, which could help lower the tariffs, a source familiar with the matter told Reuters.
Novartis and Roche did not immediately reply to requests for comment from MT Newswires.
(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)
Price: 117.82, Change: +0.97, Percent Change: +0.83
免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。